Ace XR

Quick links to important sections

Ace XR

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ace XR

Property Description
Active Ingredient Paracetamol (Acetaminophen)
Form Extended-Release Tablet (Oral)
Pharmacological Class Analgesic and Antipyretic
Common Use Sustained relief of pain and fever
Origin Synthetic (Para-aminophenol derivative)

Ace XR is a specific oral medication formulated as a single-active-ingredient Extended-Release Tablet. The sole active chemical substance is Paracetamol, commonly known as Acetaminophen. It is a synthetic compound and is both an Analgesic (pain reliever) and an Antipyretic (fever reducer), making its general purpose the symptomatic comfort from mild-to-moderate pain and the management of elevated body temperature.


What Type of Medication is Ace XR and What is it Made Of?

Ace XR is categorized as a Non-Opioid Analgesic and belongs to the para-aminophenol chemical class. Paracetamol is a foundational treatment for pain and fever. The active ingredient is a monosegmental drug, meaning it contains only Paracetamol, distinguishing it from combination products. Its action, which involves centrally mediated effects on the nervous system, sets it apart from non-steroidal anti-inflammatory drugs (NSAIDs) as it does not target significant peripheral inflammation.


Understanding the Extended-Release (XR) Formulation

The key differentiator of this medicine is its XR designation, which signifies an Extended-Release Tablet designed as a sustained-release oral formulation. This delivery mechanism is designed to provide a controlled absorption profile, which is particularly beneficial for conditions requiring consistent pain relief.

This specialized solid oral matrix is engineered to control the speed at which the Paracetamol is absorbed, releasing the active ingredient slowly and consistently over a prolonged duration. The sustained-release action ensures that the therapeutic effect lasts longer than that of standard immediate-release forms, supporting continuous management of discomfort.


What is the General Purpose of Ace XR?

The general therapeutic purpose of Ace XR is to reduce fever by assisting the brain's thermoregulation center and to alleviate pain by elevating the body's pain threshold. Sustained-release forms are designed to facilitate patient compliance by maintaining stable drug levels for longer periods. By targeting these essential processes, Ace XR provides predictable symptomatic relief.

What side effects are possible with Ace XR?

Possible side effects and safety information

The official safety profile for Paracetamol (Acetaminophen) is categorized by the specific organ systems and frequency of adverse reactions documented in regulatory sources.


Adverse Reaction Classifications

Adverse events are formally grouped into System-Organ Classes (SOCs), which include Hepatobiliary Disorders (liver), Immune System Disorders, Skin and Subcutaneous Tissue Disorders, and Blood and Lymphatic System Disorders. According to official regulatory standards, most adverse reactions—such as mild gastrointestinal effects and hypersensitivity reactions—are classified as Rare or Very Rare.

Serious Safety Considerations

The most critical safety information documented in official labels relates to the potential for serious adverse reactions. These include Acute Liver Failure, which is explicitly tied to the risk of hepatic necrosis (severe liver damage) when the maximum therapeutic dose is exceeded. Furthermore, rare but life-threatening Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Acute Generalized Exanthematous Pustulosis (AGEP), are documented in the official safety profile.


Safety Constraints and Special Populations

Official labels define specific constraints necessary for safe use. The risk of acute liver failure is dose-dependent, mandating strict adherence to the maximum daily dose constraint. Specific regulatory caution is noted for individuals with Severe Hepatic or Renal Impairment. Additionally, individuals with Chronic Alcohol Use are documented in safety information as being at an increased risk of hepatic toxicity. The use of any other paracetamol-containing products must be restricted to avoid accidental overdose.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented overdose information for Ace XR (Paracetamol/Acetaminophen Extended-Release), strictly based on governmental regulatory guidance.


Documented Overdose Symptoms and Risk

Element Official Regulatory Statement
Documented Overdose Presentations Early symptoms are often non-specific and may include nausea, vomiting, diaphoresis (sweating), abdominal pain, and lethargy. Delayed signs of severe toxicity involving the hepatic system may include jaundice (yellowing of the skin/eyes) and confusion (1.1, 2.3).
Serious / Life-Threatening Outcomes Overdose can lead to severe liver damage (hepatotoxicity), acute liver failure, and death. In extreme cases, a liver transplant may be required (1.3, 4.1).
Population-Specific Overdose Notes The risk of severe hepatic injury is heightened in patients with hepatic impairment, chronic alcohol use, malnutrition, or severe renal impairment (1.6, 2.2).

Required Emergency Actions and Monitoring

Element Official Regulatory Statement
When Immediate Medical Help is Required Seek immediate medical help or contact a Poison Control Center (e.g., 1-800-222-1222) right away if an overdose is suspected. Quick medical attention is critical even if no signs or symptoms are noticed (1.4).
Antidote and Supportive Measures The designated antidote is N-acetylcysteine (NAC). Administration must begin immediately to achieve maximal protection against liver damage, as efficacy diminishes progressively after 8 hours post-ingestion (1.5, 3.1).
Monitoring Constraints for Extended-Release (XR) Due to delayed absorption with the XR formulation, the regulatory protocol requires specific laboratory testing, including a second plasma acetaminophen concentration measurement at 8 to 10 hours after acute ingestion (1.4).

Connection to the Overall Overdose Profile:

Regulatory documents define the overdose profile by a high risk of life-threatening, delayed toxicity despite potentially mild initial symptoms. The mandate to seek immediate medical attention reflects the need to initiate time-critical antidote therapy within the 8-hour window to prevent the subsequent severe hepatic outcomes and the requirement for specialized laboratory monitoring due to the Extended-Release formulation.

Therapeutic Uses of Ace XR

Ace XR may be part of symptomatic management for symptoms related to physical discomfort and systemic imbalance. This medication is commonly used to help with temporary relief of minor aches and pains and temporary reduction of fever. It is relevant when supportive symptom management is appropriate.

It is commonly used for managing symptom clusters associated with acute or episodic changes, including symptoms that interfere with daily comfort, such as headache, toothache, muscular aches, backache, and menstrual cramps.

“The extended-release formulation may assist with supporting the patient during difficult episodes, contributing to improved comfort during periods of heightened symptoms, and helping to ease the overall symptom load.”

This therapeutic domain is commonly used in scenarios where symptoms related to physical discomfort become more disruptive, such as the minor pain of arthritis and chronic backache, where a sustained profile may be considered relevant for easing discomfort. It is applied in settings marked by temporary physiological imbalance to help with managing fever and the generalized aches common with the cold and flu. This may be relevant for easing symptoms that interfere with daily functioning, contributing to supportive relief.


Quick Fact: Support for Recurrent Discomfort

The extended-release function may be part of symptomatic management for conditions characterized by recurrent or ongoing symptoms that create noticeable physiological strain, assisting with a potentially longer-lasting effect.

Regulatory References

  1. DailyMed official label for Acetaminophen Extended Release

Eligibility and Restrictions for Use

Official Eligibility and Restrictions for Ace XR

Ace XR (Extended-Release Paracetamol/Acetaminophen) eligibility is strictly defined by regulatory documents, outlining populations permitted to use the medicine and those who are formally contraindicated.

Who Must Not Use (Contraindications):

Classification Population/Condition
Absolute Contraindication Known hypersensitivity or allergy to acetaminophen or any component [DailyMed].
Absolute Contraindication Severe hepatic impairment or active liver disease [NIH StatPearls].
Age Restriction Children younger than 12 years of age [DailyMed].

Conditional and Restricted Use:

Use is restricted for specific populations who must consult a health professional prior to use, as required by the official label. This includes individuals with pre-existing liver disease, those with a history of chronic alcohol misuse, and individuals who are pregnant or nursing [MedlinePlus; DailyMed].

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory documents for Ace XR (Extended-Release Paracetamol/Acetaminophen) define several mandatory interaction constraints. Co-administration with any other medicinal product containing acetaminophen (Paracetamol) is formally contraindicated by regulatory agencies to prevent the documented risk of dose-related severe liver damage.

Pharmacodynamically, the prolonged regular daily use of this medicine enhances the anticoagulant effect of warfarin and other coumarins, which may increase the risk of bleeding. Medicines that alter absorption rate include metoclopramide, which may increase the speed of uptake, and cholestyramine, which reduces absorption and must not be administered within one hour of Ace XR.

The risk of paracetamol toxicity is increased when used concomitantly with liver enzyme inducers, including the herbal product St. John’s Wort and certain anticonvulsants like phenytoin. Severe liver damage is documented to occur if the product is taken by an individual who consumes three or more alcoholic drinks every day. There is also a documented association between the co-administration of Ace XR and flucloxacillin with the risk of High Anion Gap Metabolic Acidosis (HAGMA). These risks are further heightened in populations with underlying liver disease or conditions leading to glutathione depletion.

Mechanism of Action

Ace XR’s mechanism of action is primarily centralized, focusing on molecular targets within the Central Nervous System (CNS) to modulate nociceptive and thermal regulatory pathways.

Modulation of Central Prostaglandin Synthesis

This mechanism involves the functional inhibition of Cyclooxygenase (COX) enzymes located in the brain and spinal cord. This interaction reduces the central synthesis of Prostaglandin E2 ( PGE2), a key signaling molecule that mediates both pain sensitization and the elevation of the body's temperature set point.

Potentiation of Descending Inhibitory Pain Pathways

Beyond PGE2 reduction, the drug is metabolized into AM404, which acts to modulate central pathways by indirectly enhancing the endocannabinoid system and directly activating TRPV1 receptors. This dual molecular action strengthens the body's natural inhibitory systems, modifying the central pain threshold and modulating nociceptive signal transmission.

Mechanism-Driven Duration via Extended-Release

The Extended-Release (XR) formulation is a pharmaceutical design mechanism engineered to ensure a slow, consistent absorption profile. This continuous availability helps maintain the concentration required to engage the central targets (COX, TRPV1, CB1 systems) over a prolonged duration, thereby sustaining the modulation of thermal regulatory and nociceptive pathways.

Dosage and Administration Information

How to Use Ace XR: Administration Principles

Ace XR (Acetaminophen Extended-Release Tablet, 650 mg) is used according to specific administration patterns dictated by its specialized formulation, which provides sustained analgesic and antipyretic activity. The route of administration for this form of the medicine is oral.


Standard Adult Dosing and Frequency

The standard adult dosing regimen is two 650 mg caplets taken at one time, which constitutes a single dose of 1300 mg. This dosage is designed to maintain a stable level of the active substance over a prolonged period. The dosing frequency is established at every eight hours (q8h). The overall maximum recommended daily dose for adults must not exceed six caplets (3900 mg total) in a 24-hour period.


Key Administration Instructions

Administration Constraint Procedural Requirement
Physical Integrity The caplet must be swallowed whole; it must not be crushed, chewed, split, or dissolved to preserve the extended-release mechanism.
Intake Condition The medication is administered orally with water.
Duration Limit For temporary self-medication, use for pain should not extend beyond 10 days, or 3 days for fever, unless directed by a healthcare professional.

Population-Specific Use

This formulation is not for use in children under the age of 12 years. For individuals under 18 years of age, consultation with a doctor is required to determine appropriate use. For adults with impaired kidney or liver function, the standard fixed-dose may be unsuitable and use should be managed by a doctor, as the necessary maximum daily intake of Paracetamol is often lower.

Recent Clinical Evidence

Evidence for Sustained Relief of Osteoarthritis Pain

Research has explored the use of the active ingredient in Ace XR for conditions characterized by fluctuating or episodic manifestations (osteoarthritis), a condition involving periods of heightened symptoms in joints like the hip or knee. The main evidence comes from short- to medium-term Randomized Controlled Trials (RCTs), typically lasting from six weeks up to three months, where the active ingredient was studied for outcomes related to physical discomfort. These studies included adult populations and research examined how outcomes reflecting daily functioning or activity level changed over the course of the trial.

Studies monitored how outcomes related to physical discomfort and mobility assessments were measured in the observed populations. Findings describe patterns related to the specific time points and assessment tools used in the studies. Research also was studied for the specific extended-release (XR) design to see how its sustained-release profile compares to the immediate-release (IR) version.

However, long-term outcomes are not fully established because the follow-up durations were limited in many pivotal trials. The evidence consistency may vary across studies, and there is an ongoing scientific discussion about the magnitude of change observed in these outcomes related to systemic or functional imbalance. Data for certain groups remain limited, particularly those with more severe or advanced disease.

Evidence for Managing General Acute Pain and Fever

The general use of this medicine for temporary relief of acute, mild-to-moderate pain and for research examining temporary physiological imbalance (fever) was evaluated in a structure of research that includes single-dose and short-term multi-dose RCTs. This research is relevant in trials assessing short-term or episodic symptom patterns and research monitored how quickly changes were measured and the duration of observation was maintained.

The primary evidence for the XR form was studied for its unique design—sustaining blood levels over time—rather than demonstrating a separate or higher maximum level of initial symptom change. The findings contribute to understanding symptom patterns because the research explored how the controlled-release mechanism was associated with stable drug concentrations over time.

Key Studies & References

  1. Label: ACETAMINOPHEN tablet, extended release - DailyMed (Used for official indications and basic formulation data)

Frequently Asked Questions (FAQ)

Common questions about Ace XR (FAQ)


Q: How is Ace XR different from the immediate-release (IR) version of the same medicine?

A: Official product information notes that the key difference is in the medicine's delivery design. The 'XR' stands for Extended-Release, meaning the medicine is formulated to be absorbed slowly and consistently over a prolonged period. This contrasts with immediate-release versions, which are absorbed more quickly into the body.


Q: Will Ace XR cause the same side effects as the immediate-release version?

A: Official labeling confirms that both the immediate-release and extended-release versions contain the same active ingredient. Therefore, critical safety warnings, such as the potential for severe skin reactions or liver failure, are associated with the active ingredient itself. Official regulatory documents do not provide a direct comparison of the frequency of mild or common side effects between the two formulations.


Q: How long does Ace XR typically take for people to notice a change or feel the effects?

A: Because Ace XR is designed to release the ingredient slowly and consistently over time, it differs from immediate-release medicines. Official documents focus on the sustained release profile rather than specifying an exact time for the initial change in symptoms.


Q: What is the typical duration of action for a single dose of Ace XR?

A: The formulation is engineered for sustained activity. The dosing is based on the expectation that the medicine will sustain a stable concentration of the active substance over the eight-hour interval.


Q: What are the most common or frequently reported side effects of Ace XR?

A: The active ingredient is generally well-tolerated when administered in therapeutic doses. Regulatory documents describe mild gastrointestinal effects, such as nausea and constipation, as reactions that have been reported with the active ingredient.


Q: Can Ace XR be taken by people who are sensitive to certain inactive ingredients?

A: Official contraindications require that the medicine must not be used by people who have a known allergy or hypersensitivity to the active ingredient or any component of the product. This includes the inactive ingredients, also known as excipients.


Q: Is Ace XR appropriate for use in children or adolescents?

A: Official product labeling specifies that this extended-release formulation is not for use in children under the age of 12 years. For individuals who are between 12 and 18 years of age, official documents state that consultation with a doctor is required to determine appropriate use.


Q: Does Ace XR interact with common supplements like vitamins or herbal products?

A: Regulatory documents cite specific interactions, such as an increased risk of toxicity with liver enzyme inducers, including the herbal product St. John’s Wort. There is no general regulatory statement covering all common vitamins or other supplements.


Q: Does taking Ace XR affect my ability to drive or operate machinery?

A: Official patient warnings state that this medicine is not likely to affect the ability to drive or use machines. Official documents state that individuals should observe how the product affects them before operating machinery.


Q: What does the research evidence say about the long-term use of Ace XR?

A: The official research summaries for this medicine indicate that most evidence comes from short- to medium-term studies, typically lasting up to three months. The official summaries indicate that long-term outcomes are not fully established because data collection and follow-up durations were limited in many pivotal trials.


Q: Will I experience withdrawal symptoms if I stop taking Ace XR?

A: Ace XR is officially classified as a Non-Opioid Analgesic. Medications in this class are not typically associated with physical dependence leading to withdrawal symptoms when usage is discontinued.


Q: Is it normal to see part of the pill in my stool after taking Ace XR?

A: The extended-release technology uses a solid tablet matrix designed to release the active ingredient slowly and consistently. After the medicine is fully absorbed, the inactive outer casing or matrix of the tablet may remain physically intact and may sometimes be visible in the stool.


Q: Is it true that the effectiveness of Ace XR is consistent throughout the entire day?

A: The extended-release formulation is a specialized pharmaceutical design engineered to ensure a slow, consistent absorption profile. The purpose of this design is to help maintain a stable concentration in the body throughout the eight-hour dosing interval.


Q: Can Ace XR make me feel dizzy or lightheaded, especially when standing up?

A: Official safety data has documented dizziness as an adverse reaction that can be experienced by individuals taking the active ingredient.


Q: Does the time of day I take Ace XR matter for its effectiveness?

A: The official administration instructions strictly specify adherence to the fixed interval of every eight hours (q8h). However, they do not designate a required time of day for the first dose.


Q: Are there different forms or strengths of Ace XR available?

A: Ace XR is described in official documents as a specific oral medicine formulated as an Extended-Release Tablet containing 650 mg of the active ingredient.


Q: Is Ace XR gluten-free or suitable for people with dietary restrictions?

A: The regulatory label lists all inactive ingredients and excipients. Patients should review the full product information to verify the source of these ingredients if they have specific dietary restrictions.


Q: Is Ace XR considered a habit-forming or addictive medication?

A: Ace XR is officially categorized as a Non-Opioid Analgesic and is not classified as a controlled substance. It is not considered to be habit-forming or cause physical dependence when taken as directed.


Q: How long does the body take to fully eliminate Ace XR after the last dose?

A: Official pharmacokinetic data indicates that most of the medicine is processed and eliminated by the body within a day. Over 90% of the administered dose's metabolites are typically eliminated in the urine within 24 hours after the last dose.


Q: Is Ace XR safe to take if I have diabetes or blood sugar issues?

A: Regulatory documents indicate that the active ingredient may potentially cause false results with certain blood glucose tests. Individuals with diabetes should be aware of this potential interference with testing.


Q: Does Ace XR affect sleep patterns or cause insomnia?

A: Official safety data has documented insomnia (difficulty falling or staying asleep) as a psychiatric adverse reaction that can be experienced by some individuals taking the active ingredient.


Q: Can I take over-the-counter (OTC) pain relievers while using Ace XR?

A: Regulatory documents strictly contraindicate the use of Ace XR with any other medicine that contains acetaminophen (Paracetamol). This is a mandatory safety restriction intended to prevent the documented risk of severe liver damage from accidental overdose.


Q: What happens if I miss a dose of Ace XR?

A: Official guidance describes the procedure for a missed dose as taking the dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, only the next dose should be taken. It is specifically advised that extra or double doses must not be taken.


Q: Can traveling across time zones affect when I should take Ace XR?

A: The official administration instructions define the dosing frequency as strictly set at every eight hours (q8h). Official documents do not provide a specific regulatory protocol for adjusting the schedule when crossing time zones.


Q: What should I tell a healthcare provider before starting Ace XR?

A: Official warnings specify that a healthcare provider should be informed prior to starting this medicine if an individual has pre-existing liver disease, consumes three or more alcoholic drinks every day, or is taking the blood-thinning drug warfarin.


Q: What is the consensus in major medical guidelines about using Ace XR for its approved condition?

A: The active ingredient in Ace XR is officially classified as a Non-Opioid Analgesic and Antipyretic. Due to its defined effects, clinical guidelines often recognize this active ingredient as a foundational treatment for pain and fever.


How should Ace XR be stored and disposed of?

Storage and Disposal of Ace XR (Paracetamol Extended-Release Tablet)

Storage Conditions

Ace XR must be stored at Controlled Room Temperature, defined as 20° to 25°C (68° to 77°F). The tablets should be kept in the original container, tightly closed, and protected from high humidity and excessive heat that exceeds 40°C (104°F). As with all medicines, it must be stored out of the reach of children.

Disposal Requirements

Expired or unused Ace XR should not be flushed down the toilet or poured down a sink. The preferred disposal method is through an authorized medicine take-back program. If a take-back option is unavailable, the tablets should be mixed with an undesirable substance, such as dirt or used coffee grounds, placed in a sealed container, and discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Ace XR found in:

A-Z Index: